Research / HIND / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-23-013645 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.60% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-295.56% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-22.06% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
144.99% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
52.97% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-176.40% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.78% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
9.63% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 6/8 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 6/6 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.31%
Current 1.60%
Delta 1.29% Cash Generation Decreased
Previous -221.29%
Current -295.56%
Delta -74.27% Growth Decreased
Previous -6.27%
Current -22.06%
Delta -15.79% Inventory Pressure Decreased
Previous 152.73%
Current 144.99%
Delta -7.75% Margin Decreased
Previous 53.52%
Current 52.97%
Delta -0.55% Profitability Increased
Previous -246.22%
Current -176.40%
Delta 69.82% R And D Intensity Increased
Previous 19.81%
Current 25.78%
Delta 5.97% Sbc Intensity Decreased
Previous 9.71%
Current 9.63%
Delta -0.08% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.